SCN9A: Proposal of Voltage-Gated Ion Channels as a Novel Diagnostic Marker for Alzheimer's Disease
Shah, D.; Shah, R.; Waldron, A.; Leonardi, D.
Show abstract
Alzheimers disease (AD) is an age-related neurodegenerative disease that affects over 6 million adults each year. As individuals age, their cells do not repair themselves which leads to proliferation arrest known as senescence. In the nervous system, astrocyte senescence has been associated with neuroinflammation and other AD processes. Thus, studying senescence may be a unique approach to understanding AD pathology. This study looks at the correlation between SCN9A, a novel gene target, and AD. Results suggest SCN9A may be a potential diagnostic marker for AD. A model was created with an 80%+ accuracy rate in predicting AD. Overall, this study suggests SCN9A plays a large role in neurodegeneration and treating AD.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Exenatide reverts the high-fat-diet-induced impairment of BDNF signaling and inflammatory response in an animal model of Alzheimer’s disease 96%
- Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 95%
- The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa 94%
Similar papers in this journal
- Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease 96%
- Interactive Effects of Telomere Length and Genetic Variants on Alzheimer Disease Risk Across Multiple Ancestral Populations 95%
- Considerations regarding a diagnosis of Alzheimer’s Disease before dementia: a systematic review 94%
Similar papers in this journal
- Common molecular signatures between coronavirus infection and Alzheimer's disease reveal targets for drug development 96%
- The tryptophan catabolite or kynurenine pathway in Alzheimer’s disease: a systematic review and meta-analysis 95%
- Association of GLOD4 with Alzheimers Disease in Humans and Mice 94%
Similar papers in this journal
Similar papers in this journal
- Biological and Disease Hallmarks of Alzheimer’s Disease Defined by Alzheimer’s Disease Genes 95%
- Phenotyping Neuropsychiatric Symptoms Profiles of Alzheimer's Disease Using Cluster Analysis on EEG Power 94%
- Early functional and cognitive declines measured by auditory evoked cortical potentials in Alzheimer's disease mice 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.